InvestorsHub Logo
Followers 46
Posts 8390
Boards Moderated 0
Alias Born 05/27/2011

Re: flipper44 post# 657445

Wednesday, 12/20/2023 11:05:45 AM

Wednesday, December 20, 2023 11:05:45 AM

Post# of 704237
The lesson learned from DCVax-L Phase III clinial trial related to the recurrent patients may give the Doctors idea to have these extra doses to be applied to recurrent cases. We know DCVax-L works really great for recurrent cases. Combinations also have been tested with recurrent cases. Good for patients to have options even when the cancers recur. Impo.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News